Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients

Table 1 Baseline characteristics of subjects in the different groups n (%)

	Non-HBV infected (n = 105)	HBsAg(-)/HBcAb(+) (n = 32)	HBsAg(+) (n = 25)	P value
Gender				0.582
Male	69 (65.71)	22 (68.75)	14 (56)
Female	36 (34.29)	10 (31.25)	11 (44)
Age (yr)	31.35 ± 11.88	32 ± 10.31	32.48 ± 9.66	0.887
Type of disease1				0.576
Acute myeloid leukemia	44 (41.90)	18 (56.25)	15 (60)
Acute lymphoblastic leukemia	30 (28.57)	6 (18.75)	6 (24)
Aplastic anemia	16 (15.24)	4 (12.50)	1 (4)
Others	15 (14.29)	4 (12.50)	3 (12)
Methods of transplantation				0.548
Sibling	80 (76.19)	21(65.63)	20 (80)
Unrelated	21 (20.00)	9 (28.13)	3 (12)
Haploidy	4 (3.81)	2 (6.25)	2 (8)

¹Represented Fisher’s exact tests used. Continuous variables were presented as mean ± SD or median (ranges). Categorical variables were presented as counts and percentages.